Author: devcuration

In 2021, while most of the market was busy arguing about software eating the world, a different conversation was happening quietly in Mountain View. Alexander Shpunt, Arman Hajati, and Yuval Gerson were staring at robots that could move but could not really see. Not metaphorically. Literally. These machines were surrounded by cameras, depth sensors, and inertial units that refused to agree with each other. Perception was fragmented, brittle, and expensive, and Physical AI was paying the tax every single day. This is the context behind Lyte stepping out of stealth with $107 million in total funding, announced January 5, 2026.…

OrangeTwist never sounded like a spa brand that wanted to whisper. It always felt like a signal flare. Bright, deliberate, impossible to miss. When SBC Medical Group Holdings decided to plant a flag in the United States aesthetics market, it did not knock quietly. It chose OrangeTwist, and that choice says more than any press release ever could. Founded in 2015 by Dr. W. Grant Stevens and Clint Carnell, OrangeTwist grew the hard way. 24 locations across 6 states did not come from chasing trends. They came from understanding that aesthetics is not vanity, it is confidence economics. People do…

Trustwell did not arrive at this moment by accident. It arrived by accumulation. 40 years of nutrition data. Two decades of traceability scars. Millions of decisions made quietly behind the label, behind the supplier portal, behind the recall drill no one wants to run but everyone eventually does. Food safety is not loud, but it remembers everything. When TPG’s The Rise Funds stepped in with a majority investment, and The Riverside Company stepped out, this was not a victory lap. It was a handoff. One operator to another. One chapter closing so the next one could move faster, with more…

Interos.ai used to be polite fiction. Tier one looked clean, tier two felt manageable, and everything after that lived in a spreadsheet no one trusted. Then the world caught fire. Pandemics, cyberattacks, sanctions lists multiplying like rabbits, hurricanes with opinions. Suddenly “we didn’t know” stopped working as an excuse. Enter Interos.ai, a company that looked at global complexity and said cool story, now show me every connection. Founded in 2005 by Jennifer Bisceglie, Interos started with a simple, uncomfortable truth. Companies do not actually know who they are doing business with. Not fully. Not at scale. What began as hard-earned…

Mitera Biosciences did not come out of stealth waving its arms. It surfaced the way serious biology does, quietly, deliberately, with receipts. A $1.75 million seed round filed with the SEC, announced December 30, 2025, and a mission rooted in something most of modern immunology forgot to respect. The human body already knows how to tolerate what should not belong. Pregnancy figured it out long before biotech showed up with spreadsheets. Based in Bellevue, Washington, Mitera Biosciences is building safer alternatives to traditional immunosuppressive therapies for transplant rejection and autoimmune disease by studying that biological ceasefire. During pregnancy, the immune…

Every generation gets the interface it deserves. First it was the phone book, then Google, then the blue links arms race. Now it is a calm, confident paragraph from an AI that sounds like it knows you, your boss, and your buying committee. That paragraph decides who exists and who does not. San Francisco based Unusual just raised $3.6M to deal with that reality, and pretending this is a marketing footnote is how brands quietly disappear. Unusual is the first company built specifically to understand and change how AI talks about you. Not clicks. Not rankings. Conversations. When ChatGPT, Claude,…

Marketecture Media just raised a $1 million seed round, and if you think this is about microphones and newsletters, you are missing the plot. This is about control of narrative in an industry that sells narrative for a living. Advertising runs on signal, trust, and timing. Marketecture figured out that the people who actually build the machinery should be the ones explaining how it works, not spectators with press passes. Founded in March 2022 by Ari Paparo and Zach Rodgers, Marketecture started as a product idea disguised as media. Ari Paparo did not come from journalism. He came from the…

January 5, 2026 does not scream for attention. It does not need to. Azimuth AI just closed a growth round led by Jetha Global, and anyone who has lived through real silicon cycles knows this is the part of the story where things stop being loud and start being inevitable. No disclosed number. No victory laps. Just capital aligning with execution, timing, and a team that understands physics is undefeated. Azimuth AI was founded in 2022 in Sacramento, with engineering muscle in Hyderabad and operational gravity pulling through Folsom. Praveen Yasarapu and Sridevi Badiga did not set out to build…

Materials usually live in the background. Quiet, unglamorous, absolutely unforgiving. Software gets the applause, hardware gets the photos, but nothing flies, reenters, or survives heat without chemistry that does not blink when physics gets aggressive. Cambium Biomaterials did not raise its voice to get attention. It raised the floor. Founded in 2019 by Simon Waddington and Stephan Herrera, Cambium Biomaterials was built by people who have already seen what breaks at scale. Simon Waddington brought decades across petrochemicals, specialty polymers, biotech ops, and venture creation. Stephan Herrera came with a rare mix of scientific fluency and narrative discipline after years…

VisaPal did not tiptoe into immigration tech. It walked in with forms finished, evidence labeled, and a system that actually respects how high the stakes are. Founded in 2025 and launched live in December, this Manhattan-based platform is staring straight at one of the most overloaded bureaucratic machines in America and asking a dangerous question. Why does a life defining process still feel like it was duct taped together decades ago? Fraser Spivey is the Founder driving it forward. Four-time entrepreneur. Investor across tech, biotech, and mining. Australian born, Africa raised, New York sharpened. VisaPal is not an experiment. It…